UB Paderborn / Katalog / Suche / in CDI

1 – 13 von 13

Sortiert nach

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

The Lancet (British edition), 2005-09, Vol.366 (9489), p.907-913

2005

Link zum Volltext

Verfügbarkeit prüfen

Use of ramipril in preventing stroke: double blind randomised trial

BMJ (Online), 2002-03, Vol.324 (7339), p.699-702

International edition, 2002

Link zum Volltext

Verfügbarkeit prüfen

Why Medical Students Choose to Use or Not to Use a Web-Based Electrocardiogram Learning Resource: Mixed Methods Study

JMIR medical education, 2019-07, Vol.5 (2), p.e12791-e12791

2019

Link zum Volltext

Verfügbarkeit prüfen

Review: From Hypertension to Heart Failure — Are There Better Primary Prevention Strategies?

Journal of the Renin-Angiotensin-Aldosterone System, 2006-06, Vol.7 (2), p.64-73

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers

Journal of the renin-angiotensin-aldosterone system, 2006-03, Vol.7 (1_suppl), p.S1-S7

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Commentary

The Lancet (British edition), 2003, Vol.362 (9386), p.772-776

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme. Commentary

The Lancet (British edition), 2003, Vol.362 (9386), p.754-755

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial. Commentary

The Lancet (British edition), 2003, Vol.362 (9386), p.754-771

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Commentary

The Lancet (British edition), 2003, Vol.362 (9386), p.754-781

2003

Link zum Volltext

Verfügbarkeit prüfen

Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival

Journal of internal medicine, 2014, Vol.276 (1), p.87-95

2014

Link zum Volltext

Verfügbarkeit prüfen

Travers mellan ordprakt och förfall

World Literature Today, 1982, Vol.56 (3), p.531-531

Atkinson, J. L.

1982

Link zum Volltext

Verfügbarkeit prüfen

1 – 13 von 13

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieEuropean Journal Of Heart Failure

ThemaFemale

ThemaPeripheral Vascular Disease

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(13)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(12)
Reviews
(1)

Sprache

Englisch
(13)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Use of ramipril in preventing stroke: double blind randomised trial

Why Medical Students Choose to Use or Not to Use a Web-Based Electrocardiogram Learning Resource: Mixed Methods Study

Review: From Hypertension to Heart Failure — Are There Better Primary Prevention Strategies?

Clinical Evidence for the Cardiovascular Benefits of Angiotensin Receptor Blockers

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Commentary

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: The CHARM-Overall programme. Commentary

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: The CHARM-Added trial. Commentary

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Commentary

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial: Lipid Lowering Arm (ASCOTtLLA): a multicentre randomised controlled trial. Commentary

Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival

Travers mellan ordprakt och förfall

Aktive Filter

Suchergebnisse filtern